Clinical trial
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients…
NCT01193348 · Alexion Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT01193348 |
|---|---|
| Title | An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome |
| Official title | An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome |
| Acronym | aHUS |
| Lead sponsor | Alexion Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atypical Hemolytic-Uremic Syndrome |
| Intervention type | Drug |
| Interventions | Eculizumab |
| Enrollment | 22 |
| Start date | Sep 1, 2010 |
| Primary completion | Jan 1, 2014 |
| Completion | Apr 1, 2014 |
| First posted | Sep 1, 2010 |
| Last update posted | Apr 29, 2015 |
| Countries | Australia, Belgium, Canada, France, Germany, Italy, Netherlands, United Kingdom, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: